On Demand CE: Therapies that Work - Translating their Optimal Use into Clinical Practice


Our 2015 Fall Learning Series featured three topics on the theme of translating therapies into their the optimal use in clinical practice.
  • Secondary Prevention Cocktail: The Key Ingredients; Speaker Alan Brown MD
  • Statins and Beyond: New Tools for the Challenging Patient; Speaker Nancy Dagefoerde APN
  • Managing VTE: Matching Patient Need to Optimal Therapy; Speaker Heather A. Hall MD
Credit: 2.25 CE Contact Hours, 1.25 Pharmacology
Cost: Free

Take this Course

Upon completion of the course, participants will be able to:

  • Review the secondary prevention guidelines for the post-ACS patient
  • List the specific strategies that have proven efficacy for patients at risk for nonadherence
  • Describe best practice recommendations for navigating the challenging hospital-to-home transition for the ACS patient
  • Describe an evidence-based therapeutic approach to the patient with a true intolerance to statin therapy.
  • Outline a treatment plan for the patient who has an inadequate response to high-intensity statin therapy, including strategies to rule out sub-optimal adherence and optimization of patient education
  • Describe the integration of shared decision-making into the clinical encounter for a patient with elevated LDL-cholesterol
  • Identify prevalence rates of venous thromboembolism (VTE), including rates for morbidity and mortality
  • Discuss professional guidelines that stress methods for assessing risk in patients with VTE and provide algorithms for patient management
  • Describe methods for ensuring effective communications with patients and caregivers as a means of improving adherence and self-care in patients with VTE
This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is accredited by the American Association of Nurse Practitioners (AANP) as an approved provider of Nurse Practitioner continuing education, provider number 030602.